Should everyone with an ejection fraction less than or equal to 30% receive an implantable cardioverter-defibrillator? Not everyone with an ejection fraction < or = 30% should receive an implantable cardioverter-defibrillator
- PMID: 15897357
- DOI: 10.1161/01.CIR.0000165057.88551.2C
Should everyone with an ejection fraction less than or equal to 30% receive an implantable cardioverter-defibrillator? Not everyone with an ejection fraction < or = 30% should receive an implantable cardioverter-defibrillator
Comment in
-
Should everyone with an ejection fraction less than or equal to 30% receive an implantable cardioverter-defibrillator? Everyone with an ejection fraction < or = 30% should receive an implantable cardioverter-defibrillator.Circulation. 2005 May 17;111(19):2537-49; discussion 2537-49. Circulation. 2005. PMID: 15900623 No abstract available.
Similar articles
-
Should everyone with an ejection fraction less than or equal to 30% receive an implantable cardioverter-defibrillator? Everyone with an ejection fraction < or = 30% should receive an implantable cardioverter-defibrillator.Circulation. 2005 May 17;111(19):2537-49; discussion 2537-49. Circulation. 2005. PMID: 15900623 No abstract available.
-
Effectiveness of implantable cardioverter-defibrillators for the primary prevention of sudden cardiac death in women with advanced heart failure: a meta-analysis of randomized controlled trials.Arch Intern Med. 2009 Sep 14;169(16):1500-6. doi: 10.1001/archinternmed.2009.255. Arch Intern Med. 2009. PMID: 19752408
-
Can microvolt T-wave alternans testing reduce unnecessary defibrillator implantation?Nat Clin Pract Cardiovasc Med. 2005 Oct;2(10):522-8. doi: 10.1038/ncpcardio0323. Nat Clin Pract Cardiovasc Med. 2005. PMID: 16186850 Review.
-
Risk stratification for sudden death in heart failure.Minerva Cardioangiol. 2007 Jun;55(3):379-84. Minerva Cardioangiol. 2007. PMID: 17534256 Review.
-
[Risk stratification for sudden cardiac death: should we juist consider ejection fraction?].G Ital Cardiol (Rome). 2008 Oct;9(10 Suppl 1):27S-32S. G Ital Cardiol (Rome). 2008. PMID: 19195303 Italian.
Cited by
-
Implantable Cardioverter-Defibrillators in Trials of Drug Therapy for Heart Failure: A Systematic Review and Meta-Analysis.J Am Heart Assoc. 2020 Apr 21;9(8):e015177. doi: 10.1161/JAHA.119.015177. Epub 2020 Apr 15. J Am Heart Assoc. 2020. PMID: 32290732 Free PMC article.
-
The utility of ADMIRE-HF risk score in predicting serious arrhythmic events in heart failure patients: incremental prognostic benefit of cardiac 123I-mIBG scintigraphy.J Nucl Cardiol. 2014 Aug;21(4):756-62; quiz 753-55, 763-5. doi: 10.1007/s12350-014-9919-z. J Nucl Cardiol. 2014. PMID: 25015681
-
Sudden cardiac death risk prediction: comment on "Risk factor and prediction modeling for sudden cardiac death in women with coronary artery disease".Arch Intern Med. 2011 Oct 24;171(19):1710-1. doi: 10.1001/archinternmed.2011.363. Epub 2011 Jul 25. Arch Intern Med. 2011. PMID: 21788537 Free PMC article. No abstract available.
-
Risk stratification for sudden cardiac death: current approaches and predictive value.Curr Cardiol Rev. 2009 Jan;5(1):56-64. doi: 10.2174/157340309787048130. Curr Cardiol Rev. 2009. PMID: 20066150 Free PMC article.
-
Risk stratification for sudden cardiac death: is there a clinical role for T wave alternans?Heart Rhythm. 2009 Aug;6(8 Suppl):S56-61. doi: 10.1016/j.hrthm.2009.05.025. Epub 2009 Jun 23. Heart Rhythm. 2009. PMID: 19631909 Free PMC article. Review.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical